Breaking News

Axplora’s Chasse-sur-Rhône CDMO Site in France Passes Inspection

Confirms the site’s full compliance with current Good Manufacturing Practices (cGMP).

Author Image

By: Charlie Sternberg

Associate Editor

Axplora’s Chasse-sur-Rhône CDMO site in France has successfully passed its latest on-site inspection by the French National Agency for Medicines and Health Products Safety (ANSM). Conducted in February 2025, the inspection confirmed the site’s full compliance with current Good Manufacturing Practices (cGMP), with no critical remarks or 483 observations. This achievement marks the ninth successful inspection at Chasse-sur-Rhône since 2003 and underscores Axplora’s unwavering commitment to regu...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters